Phase III clinical trials for the Novavax COVID-19 vaccine candidate conclude in the U.S. and Mexico, showing an efficacy rating of 90.4%, down from the initial estimate of 96.4% efficacy reported in March. Additionally, the vaccine candidate was also found to be 86.3% effective against the Lineage B.1.1.7 Alpha variant that originated in the United Kingdom. 2021-06-14
Florida has reported more than 10,000 cases of the Lineage B.1.1.7, Lineage P.1, and Lineage B.1.351 variants since spring break. 2021-05-9
Palestine reports their first cases of the B.1.1.7 variant first detected in the United Kingdom in 139 people from the West Bank. 2021-02-16
Kansas reports its first case of the UK variant of SARS-CoV-2 in Ellis County. 2021-02-3
Japan detects possible community spread of the B.1.1.7 variant in three people from Shizuoka with no known travel history. 2021-01-18
Catalonia reports their first case of a new variant of SARS-CoV-2 from a British resident who travelled to that region. 2021-01-7
Brazil detects their first two cases of a new variant of SARS-CoV-2 that originated in the United Kingdom. 2020-12-31
Florida confirms its first new case of the new variant of SARS-CoV-2 that originated in the United Kingdom. The individual is a Martin County man with no history of travel. 2020-12-31
COVID-19 pandemic in mainland China, Variant of Concern 202012-012020-12-24